(JEMA) JPMorgan Emerging Markets - Ratings and Ratios
Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: US46641Q2663
JEMA: Stocks, Derivatives, Futures
JPMorgan Emerging Markets Equity Core ETF (BATS:JEMA) is an exchange-traded fund that primarily invests in equity securities and related instruments economically tied to emerging markets, with a minimum of 80% of its assets allocated to this category. The funds investment portfolio includes a diverse range of equity securities, such as common stock, participation notes, and other structured notes that provide exposure to emerging market equities.
Given its diversified portfolio and focus on emerging markets, JEMA offers investors a broad-based exposure to the growth potential of these economies. Emerging markets have historically provided higher returns over the long term, albeit with higher volatility. The funds use of exchange-traded futures for efficient cash flow management suggests a proactive approach to managing liquidity and potentially mitigating risks associated with cash inflows and outflows.
Analyzing the
From a fundamental perspective, JEMAs Assets Under Management (AUM) stand at $1.192 billion, indicating a significant investor base and liquidity. A substantial AUM typically correlates with lower expense ratios and greater fund stability. Combining this with the technical analysis, a forecast for JEMA could be cautiously optimistic. If the emerging markets continue to show growth potential and the global economic conditions remain favorable, JEMA could potentially test new highs. However, given the inherent risks in emerging markets, such as currency fluctuations and geopolitical uncertainties, investors should be prepared for potential volatility.
Forecasting based on the provided data, if JEMA maintains its current trend and breaks through its 52-week high, it could target the next resistance level, potentially around $45. Conversely, a decline below the SMA50 ($39.29) could signal a correction, with support around the SMA200 ($38.65). Investors should closely monitor both technical and fundamental indicators for signs of trend continuation or reversal.
Additional Sources for JEMA ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
JEMA ETF Overview
Market Cap in USD | 1,216m |
Category | Diversified Emerging Mkts |
TER | 0.33% |
IPO / Inception | 2021-03-10 |
JEMA ETF Ratings
Growth Rating | 1.15 |
Fundamental | - |
Dividend Rating | 52.4 |
Rel. Strength | 1.13 |
Analysts | - |
Fair Price Momentum | 41.81 USD |
Fair Price DCF | - |
JEMA Dividends
Dividend Yield 12m | 2.24% |
Yield on Cost 5y | 2.02% |
Annual Growth 5y | 6.20% |
Payout Consistency | 96.2% |
Payout Ratio | % |
JEMA Growth Ratios
Growth Correlation 3m | 92.2% |
Growth Correlation 12m | 49.5% |
Growth Correlation 5y | -21.4% |
CAGR 5y | -1.08% |
CAGR/Max DD 5y | -0.03 |
Sharpe Ratio 12m | 1.11 |
Alpha | 4.42 |
Beta | 0.742 |
Volatility | 15.22% |
Current Volume | 12.7k |
Average Volume 20d | 17k |
As of June 30, 2025, the stock is trading at USD 43.06 with a total of 12,661 shares traded.
Over the past week, the price has changed by +3.09%, over one month by +5.49%, over three months by +12.55% and over the past year by +15.46%.
Neither. Based on ValueRay´s Analyses, JPMorgan Emerging Markets is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 1.15 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of JEMA is around 41.81 USD . This means that JEMA is currently overvalued and has a potential downside of -2.9%.
JPMorgan Emerging Markets has no consensus analysts rating.
According to our own proprietary Forecast Model, JEMA JPMorgan Emerging Markets will be worth about 47.8 in June 2026. The stock is currently trading at 43.06. This means that the stock has a potential upside of +10.92%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 47.8 | 10.9% |